ACCULYSE
Live / Applied — Third extension granted (statement of use) (as of 06 Nov 2025)
What this means for you
Not registered yet, but its 02 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98205862
- Mark type
- Stylized text
- Filed
- 02 Oct 2023
- Published for opposition
- 16 Apr 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 010 — Medical apparatus: Medical devices for the treatment of solid tumor cancers which deliver direct injections of drugs into the tumor or to a localized region of the body causing tumor cell lysis; Medical apparatus, namely, infusion and injection devices for locally targeted drug administration
Owner
- Syncromune, Inc., Fort Lauderdale, FL, US
- Syncromune, Inc., Fort Lauderdale, FL, US
Prosecution history
- 07 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2025 — SOU EXTENSION 3 GRANTED
- 06 Nov 2025 — SOU EXTENSION 3 FILED
- 06 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jun 2025 — SOU EXTENSION 2 GRANTED
- 09 Jun 2025 — SOU EXTENSION 2 FILED
- 09 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Dec 2024 — SOU EXTENSION 1 GRANTED
- 06 Dec 2024 — SOU EXTENSION 1 FILED
- 05 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Apr 2024 — PUBLISHED FOR OPPOSITION